Search Results - "AIGNER, Achim"
-
1
Therapeutic siRNA: State-of-the-Art and Future Perspectives
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01-09-2022)“…The highly specific induction of RNA interference-mediated gene knockdown, based on the direct application of small interfering RNAs (siRNAs), opens novel…”
Get full text
Journal Article -
2
Applications of RNA interference: current state and prospects for siRNA-based strategies in vivo
Published in Applied microbiology and biotechnology (01-08-2007)“…Within the recent years, RNA interference (RNAi) has become an almost-standard method for in vitro knockdown of any target gene of interest. Now, one major…”
Get full text
Journal Article -
3
Drug Delivery by Ultrasound-Responsive Nanocarriers for Cancer Treatment
Published in Pharmaceutics (26-07-2021)“…Conventional cancer chemotherapies often exhibit insufficient therapeutic outcomes and dose-limiting toxicity. Therefore, there is a need for novel…”
Get full text
Journal Article -
4
Gene silencing through RNA interference (RNAi) in vivo: Strategies based on the direct application of siRNAs
Published in Journal of biotechnology (25-06-2006)“…RNA interference (RNAi) offers great potential not only for in vitro target validation, but also as a novel therapeutic strategy based on the highly specific…”
Get full text
Journal Article -
5
Polyethylenimines for siRNA and miRNA delivery in vivo
Published in Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology (01-09-2013)“…The discovery of RNA interference (RNAi) as a naturally occurring mechanism for gene knockdown has attracted considerable attention toward the use of small…”
Get full text
Journal Article -
6
MicroRNA Replacement Therapy for miR-145 and miR-33a Is Efficacious in a Model of Colon Carcinoma
Published in Cancer research (Chicago, Ill.) (01-08-2011)“…MicroRNAs (miRNA) aberrantly expressed in tumors may offer novel therapeutic approaches to treatment. miR-145 is downregulated in various cancers including…”
Get full text
Journal Article -
7
Increased microtubule assembly rates influence chromosomal instability in colorectal cancer cells
Published in Nature cell biology (01-08-2014)“…Chromosomal instability (CIN) is defined as the perpetual missegregation of whole chromosomes during mitosis and represents a hallmark of human cancer…”
Get full text
Journal Article -
8
MicroRNAs (miRNAs) in colorectal cancer: from aberrant expression towards therapy
Published in Current pharmaceutical design (01-02-2013)“…MiRNAs are small noncoding RNA molecules that are often aberrantly over- or underexpressed in tumors, including colorectal cancer (CRC). Due to their capacity…”
Get more information
Journal Article -
9
A novel tyrosine-modified low molecular weight polyethylenimine (P10Y) for efficient siRNA delivery in vitro and in vivo
Published in Journal of controlled release (28-05-2016)“…The delivery of nucleic acids, particularly of small RNA molecules like siRNAs for the induction of RNA interference (RNAi), still represents a major hurdle…”
Get full text
Journal Article -
10
From the exposome to mechanistic understanding of chemical-induced adverse effects
Published in Environment international (01-02-2017)“…The exposome encompasses an individual's exposure to exogenous chemicals, as well as endogenous chemicals that are produced or altered in response to external…”
Get full text
Journal Article -
11
Nanoparticles for radiooncology: Mission, vision, challenges
Published in Biomaterials (01-03-2017)“…Abstract Cancer is one of the leading non-communicable diseases with highest mortality rates worldwide. About half of all cancer patients receive radiation…”
Get full text
Journal Article -
12
Mesoporous Silica-Based Membranes in Transdermal Drug Delivery: The Role of Drug Loss in the Skin
Published in Pharmaceutics (26-07-2024)“…Compared to other forms of drug administration, the use of Transdermal Drug Delivery Systems (TDDSs) offers significant advantages, including uniform drug…”
Get full text
Journal Article -
13
Polyethylenimine Nanoparticle-Mediated siRNA Delivery to Reduce α-Synuclein Expression in a Model of Parkinson’s Disease
Published in Molecular therapy. Nucleic acids (15-12-2017)“…RNA interference (RNAi)-based strategies that mediate the specific knockdown of target genes by administration of small interfering RNAs (siRNAs) could be…”
Get full text
Journal Article -
14
Restoration of MARCK enhances chemosensitivity in cancer
Published in Journal of cancer research and clinical oncology (01-04-2020)“…Purpose Increased ATP-binding-cassette (ABC) transporter activity is a major cause of chemotherapy resistance in cancer. The ABC transporter family member…”
Get full text
Journal Article -
15
Tyrosine-Modification of Polypropylenimine (PPI) and Polyethylenimine (PEI) Strongly Improves Efficacy of siRNA-Mediated Gene Knockdown
Published in Nanomaterials (Basel, Switzerland) (10-09-2020)“…The delivery of small interfering RNAs (siRNA) is an efficient method for gene silencing through the induction of RNA interference (RNAi). It critically…”
Get full text
Journal Article -
16
Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon Carcinoma
Published in Neoplasia (New York, N.Y.) (01-07-2013)“…Abstract PURPOSE: The provirus integration site for Moloney murine leukemia virus 1 (Pim-1) kinase is overexpressed in various tumors and has been linked to…”
Get full text
Journal Article -
17
In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(–PEG)/siRNA complexes
Published in Toxicology and applied pharmacology (01-04-2009)“…RNA interference (RNAi) represents a novel therapeutic strategy allowing the knockdown of any pathologically relevant target gene. Since it relies on the…”
Get full text
Journal Article -
18
SATB1 as oncogenic driver and potential therapeutic target in head & neck squamous cell carcinoma (HNSCC)
Published in Scientific reports (25-05-2020)“…The Special AT-rich sequence binding protein 1 (SATB1) is a genome organizer protein that controls gene expression of numerous genes by regulating chromatin…”
Get full text
Journal Article -
19
Impact of medication on blood transcriptome reveals off-target regulations of beta-blockers
Published in PloS one (21-04-2022)“…For many drugs, mechanisms of action with regard to desired effects and/or unwanted side effects are only incompletely understood. To investigate possible…”
Get full text
Journal Article -
20
Vorinostat Treatment of Gastric Cancer Cells Leads to ROS-Induced Cell Inhibition and a Complex Pattern of Molecular Alterations in Nrf2-Dependent Genes
Published in Pharmaceuticals (Basel, Switzerland) (16-08-2024)“…Histone deacetylase inhibitors (HDACi) show high antineoplastic potential in preclinical studies in various solid tumors, including gastric carcinoma; however,…”
Get full text
Journal Article